When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARFXF - Biogen and Eisai aducanumab flop pressures ProMIS down 24%
Amorfix Life Sciences Ltd
Thinly traded nano cap ProMIS Neurosciences (OTCQB:ARFXF-23.5%) is down on almost a 9x surge in volume in apparent sympathy with the drop in Biogen and Eisai after they terminated development of Alzheimer's candidate aducanumab, an amyloid beta-targeting monoclonal antibody.
More news on: ProMIS Neurosciences, Inc., Healthcare stocks news, Stocks on the move,